[Myositis caused by Pleistophora in a patient with AIDS]

A Grau1, M E Valls, J E Williams

  • 1Servicio de Medicina Interna, Hospital de Figueres, Girona.

Medicina Clinica
|December 7, 1996
PubMed

Insights

This report details a rare Pleistophora infection, a parasitic protozoan causing severe myositis in two Human Immunodeficiency Virus (HIV)-positive patients. Diagnosis requires muscle biopsy, and effective treatments remain uncertain.

Area of Science:

  • Medical Parasitology
  • Infectious Diseases
  • Human Pathology

Background:

  • Pleistophora infections are rare, with only three cases reported in medical literature.
  • Two of the three reported cases, including the current one, involved patients co-infected with Human Immunodeficiency Virus (HIV).

Observation:

  • Patients presented with myositis, characterized by fever, myalgia (muscle pain), and progressive muscle weakness.
  • Clinical laboratory findings included anemia and elevated muscle enzyme levels, indicative of muscle damage.
  • Severe cases resulted in necrotic muscle fibrosis leading to disabling contractures.

Findings:

  • Diagnosis was confirmed by identifying the Pleistophora protozoan in muscle biopsy samples.
  • While light microscopy with special stains can detect spores, electron microscopy provides the most reliable diagnostic visualization.
  • No established treatment exists for Pleistophora myositis due to its rarity.

Implications:

  • This case highlights the potential for Pleistophora to cause severe myositis, particularly in immunocompromised individuals (e.g., HIV patients).
  • Further research is needed to explore potential therapeutic options, such as albendazole, which is effective against other microsporidia genera.
  • Accurate and timely diagnosis through muscle biopsy and advanced microscopy is crucial for managing this debilitating parasitic infection.

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...